(1)
Enhanced Antitumor Efficacy of Gemcitabine through Dual-Responsive Nanoparticle-Mediated Therapy in Pancreatic Cancer. J. Can. Res. Updates 2026, 15 (3), 186-196. https://doi.org/10.30683/1929-2279.2026.15.17.